Advertisement
RSKD vs SURG
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RSKD is a Hold and SURG is a StrongBuy.
Aroon Indicator for RSKD shows an upward move is likely
RSKD's Aroon Indicator triggered a bullish signal on October 21, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 193 similar instances where the Aroon Indicator showed a similar pattern. In 140 of the 193 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 73%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on September 22, 2026. You may want to consider a long position or call options on RSKD as a result. In 68 of 97 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 70%.
The Moving Average Convergence Divergence (MACD) for RSKD just turned positive on October 21, 2026. Looking at past instances where RSKD's MACD turned positive, the stock continued to rise in 34 of 51 cases over the following month. The odds of a continued upward trend are 67%.
Following a +7.31% 3-day Advance, the price is estimated to grow further. Considering data from situations where RSKD advanced for three days, in 191 of 266 cases, the price rose further within the following month. The odds of a continued upward trend are 72%.
Bearish Trend Analysis
The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RSKD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.
RSKD broke above its upper Bollinger Band on October 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 6 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.649) is normal, around the industry mean (-1.402). P/E Ratio (-81.364) is within average values for comparable stocks, (14.914). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.824). Dividend Yield (0.000) settles around the average of (0.072) among similar stocks. P/S Ratio (2.537) is also within normal values, averaging (71.128).
The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. RSKD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 94 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RSKD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
SURG in upward trend: price expected to rise as it breaks its lower Bollinger Band on October 12, 2026
SURG may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 38 of 43 cases where SURG's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 88%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where SURG's RSI Indicator exited the oversold zone, 32 of 42 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 76%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Moving Average Convergence Divergence (MACD) for SURG just turned positive on October 21, 2026. Looking at past instances where SURG's MACD turned positive, the stock continued to rise in 36 of 45 cases over the following month. The odds of a continued upward trend are 80%.
Following a +7.52% 3-day Advance, the price is estimated to grow further. Considering data from situations where SURG advanced for three days, in 203 of 252 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SURG as a result. In 79 of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 88%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SURG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.
The Aroon Indicator for SURG entered a downward trend on October 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 31 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-0.322) is normal, around the industry mean (1.864). P/E Ratio (-0.084) is within average values for comparable stocks, (-3.740). Projected Growth (PEG Ratio) (0.474) is also within normal values, averaging (8.005). Dividend Yield (0.000) settles around the average of (0.112) among similar stocks. P/S Ratio (0.048) is also within normal values, averaging (5.777).
The Tickeron Price Growth Rating for this company is 93 (best 1 - 100 worst), indicating slightly worse than average price growth. SURG’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SURG’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
SURG | ||
|---|---|---|
OUTLOOK RATING 1..100 | 60 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 31 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 100 | |
PRICE GROWTH RATING 1..100 | 93 | |
P/E GROWTH RATING 1..100 | 8 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| RSKD | SURG | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 90% | 2 days ago 76% |
| Stochastic ODDS (%) | 2 days ago 75% | 2 days ago 83% |
| Momentum ODDS (%) | 2 days ago 70% | 2 days ago 88% |
| MACD ODDS (%) | 2 days ago 67% | 2 days ago 80% |
| TrendWeek ODDS (%) | 2 days ago 74% | 2 days ago 82% |
| TrendMonth ODDS (%) | 2 days ago 73% | 2 days ago 87% |
| Advances ODDS (%) | 2 days ago 72% | 2 days ago 81% |
| Declines ODDS (%) | 9 days ago 74% | 4 days ago 88% |
| BollingerBands ODDS (%) | 2 days ago 70% | 2 days ago 88% |
| Aroon ODDS (%) | 2 days ago 73% | 2 days ago 85% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
RSKD’s FA Score shows that 1 FA rating(s) are green while SURG’s FA Score has 2 green FA rating(s).
- RSKD’s FA Score: 1 green, 4 red.
- SURG’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
RSKD’s TA Score shows that 4 TA indicator(s) are bullish while SURG’s TA Score has 5 bullish TA indicator(s).
- RSKD’s TA Score: 4 bullish, 4 bearish.
- SURG’s TA Score: 5 bullish, 3 bearish.
Price Growth
RSKD (@Packaged Software) experienced а +10.63% price change this week, while SURG (@Major Telecommunications) price change was +5.18% for the same time period.
The average weekly price growth across all stocks in the @Packaged Software industry was -0.70%. For the same industry, the average monthly price growth was -4.23%, and the average quarterly price growth was +4.00%.
The average weekly price growth across all stocks in the @Major Telecommunications industry was -2.49%. For the same industry, the average monthly price growth was -8.94%, and the average quarterly price growth was -17.18%.
Reported Earning Dates
RSKD is expected to report earnings on Nov 11, 2026.
SURG is expected to report earnings on Nov 11, 2026.
Industries' Descriptions
@Packaged Software (-0.70% weekly)Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.
@Major Telecommunications (-2.49% weekly)Major telecommunications include companies that make communication possible across the globe – by providing voice and data transmission via multiple channels such as phone or the Internet, through airwaves or cables, through wires or wirelessly. The ease with which we connect with anyone, anywhere in the world is thanks in large part to the infrastructure created by the telecom industry. Some major telecom players include AT&T Inc., Verizon Communications Inc. and Nippon Telegraph and Telephone Corporation.
Advertisement
RSKD and
Correlation & Price change
A.I.dvisor indicates that over the last year, RSKD has been loosely correlated with COIN. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if RSKD jumps, then COIN could also see price increases.
| Ticker / NAME | Correlation To RSKD | 1D Price Change % | ||
|---|---|---|---|---|
| RSKD | 100% | +2.05% | ||
| COIN - RSKD | 51% Loosely correlated | +3.65% | ||
| RIOT - RSKD | 46% Loosely correlated | +1.82% | ||
| NET - RSKD | 45% Loosely correlated | +5.32% | ||
| CLSK - RSKD | 43% Loosely correlated | +3.80% | ||
| MDB - RSKD | 42% Loosely correlated | +6.71% | ||
More | ||||
SURG and
Correlation & Price change
A.I.dvisor indicates that over the last year, SURG has been loosely correlated with TGL. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if SURG jumps, then TGL could also see price increases.
| Ticker / NAME | Correlation To SURG | 1D Price Change % | ||
|---|---|---|---|---|
| SURG | 100% | +4.83% | ||
| TGL - SURG | 37% Loosely correlated | -2.91% | ||
| RSKD - SURG | 36% Loosely correlated | +2.05% | ||
| RXT - SURG | 34% Loosely correlated | +6.64% | ||
| PCOR - SURG | 29% Poorly correlated | +0.30% | ||
| FIRY - SURG | 29% Poorly correlated | +8.23% | ||
More | ||||